期刊文献+

氯诺昔康超前镇痛对胆道手术病人炎性细胞因子表达的影响

Effect of pre-emptive analgesia with Lornoxicam on the expression of pro-inflammatory cytokines on biliary tract operation
下载PDF
导出
摘要 目的观察氯诺昔康超前镇痛对胆道手术病人炎性细胞因子表达的影响。方法选择择期行开腹胆道手术患者40例,随机分为L、H两组,每组20例。L组患者麻醉诱导前静注氯诺昔康8mg,术后以芬太尼行静脉给药病人自控镇痛(PCIA);H组患者关腹结束时静注氯诺昔康8mg,术后也以芬太尼行PCIA。于麻醉诱导前和关腹结束时(均未给予氯诺昔康前,分别记为术前与术后0h)、术后6h、24h4个时点抽取外周静脉血,测定血清炎性细胞因子包括促炎因子白细胞介素-2(IL-2)和白细胞介素-6(IL-6),抗炎因子白细胞介素-10(IL-10)。结果两组患者术前血清IL-2、IL-6浓度变化无显著差异(P>0.05),术后0、6及24h,H组IL-2、IL-6水平显著高于L组(P<0.05)。血清IL-10浓度术前两组无差异(P>0.05),术后0、6及24h,H组IL-10水平明显低于L组(P<0.05)。结论术前使用较术后使用氯诺昔康镇痛能更有效地抑制术后炎性因子的分泌并促进抗炎因子的产生。 [ Objective ] To observe the effects of pre-emptive analgesia with lomoxicam on the expression of pro-inflammatory cytokines on biliary tract operation. [ Methods ] 40 cases who undergoing the selective open bile duet operation, were selected and randomly allocated into two groups with 20 cases each, group L and group H. Pa- tients in group L were given Lomoxicam 40 mg iv before the induction of anesthesia. After the operation, Fentanyl was administered via PCA. In group H, patients were given Lomoxicam 8 mg at the end of operation. After the operation, Fentanyl was also administered via PCA. The levels of proinflammatory factors IL-2 and IL-6, anti-inflammatory factor IL-10 in serum ahead of anesthesia induction and at Oh, 6h, 24h after operation were measured by radioimmunoassay. [Results] There was no significantly difference between group L and group H in serum levels of IL-2 and IL-6 ahead of anesthesia induction (P 〉0.05). The serum levels of IL--2 and IL-6 in group H were significantly higher than group L at 0 h, 6 h, 24 h after operation (P 〈0.05). There was no significant difference between group L and group H in serum levels of IL-10 ahead of anesthesia induction (P 〉0.05). The serum levels of IL-10 in group H was significandy decreased at 0 h, 6 h, 24 h after operation (P 〈0.05). [ Conclusion] Pre-emptive analgesia with Lomoxicam could inhibit the formation of inflammatory factors but activate the production of auti-inflammatory factors.
作者 刘景诗
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第22期3429-3431,共3页 China Journal of Modern Medicine
关键词 氯诺昔康 超前镇痛 炎性细胞因子 Lornoxicam pre-emptive analgesia pro-inflammatory cytokines
  • 相关文献

参考文献10

  • 1王京燕,王洪权.新的非甾体抗炎药物氯诺昔康[J].解放军药学学报,2002,18(4):215-217. 被引量:40
  • 2CRILE GW. The kinetic theory of shock and its preemption through Aui-as-souairon[J]. Cshakless Operation Lancet, 1913, 185: 7. 被引量:1
  • 3WOOLF CJ. Evidence for a central component of post injury pain hypersensitivity[J]. Nature, 1983, 308: 686-688. 被引量:1
  • 4马柯,江伟.超前镇痛与背根神经节外周敏感化[J].国外医学(麻醉学与复苏分册),2003,24(6):380-382. 被引量:61
  • 5WANG ZY, WANG JJ, et al. Which has the least immunity depression during postoperative analgesia-morphine, tramadol, or tramadol with lomoxicam?[J]. Clin Chim Acta, 2006, 369(1): 40-45. 被引量:1
  • 6CLIFF KS, PHILIPP L, ROBIN AS, et al. The efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysis[J]. Anesth Analg, 2005, 100: 757. 被引量:1
  • 7ZHU X, CONKLIN D, EISENACH JC. Cyclooxygenase-1 in the spinal cord piays an important role in postoperative pain [J]. Pain, 2003, 104 (1-2): 15-23. 被引量:1
  • 8KISS I. Preemptive analgesia [J]. Anesthesiaology, 2000, 93 (2): 1138-1143. 被引量:1
  • 9YAKHNO N, GUEKHT A, SKOROMETs A, et al. Analgesic efficacy and safety of lomoxicam quick-release formulation compared with diclofenac potassium: randomised, double-blind trial in acute low back pain[J]. Clin Drug Investing, 2006, 26(5): 267-277. 被引量:1
  • 10张光金,潘雷达,陆青,朱晴晖.手术前后检测IL-6的临床意义[J].上海免疫学杂志,1997,17(3):177-178. 被引量:22

二级参考文献37

  • 1[1]Pruss T P,Stroissing H,Radhofer W S,et al.Overview of the pharmacological properties,pharmacokinetics and animal safety assessment of lornoxicam[J].Postgrad.Med.J,1990,66:Suppl.4,18 被引量:1
  • 2[2]Urano H,Itoga H,Fukushima K,et al.Disposition of lornoxicam (2)-tissue distribution, foeto-placental transfer and tranfer into milk after single administration to rats[J].Kiso To Rinsho,1997,31(4):21 被引量:1
  • 3[3]Hitzenberger G,Radhofer Welte S,Takacs F,et al.Pharmacokinetics of lornoxicam in man[J].Postgrad.Med.J,1990,66:Suppl.4,22 被引量:1
  • 4[4]Turner P,Johnston-A.Clinical pharmacokinetic studies with lornoxicam[J].Postgrad.Med.J,1990,66:Suppl.4,28 被引量:1
  • 5[5]Atzpodien E,Mehdi N,Clarke D,et al.Subacute and chronic oral toxicity of lornoxicam in cynomolgus monkeys[J].Food-Chem-Toxocol,1997,35:ISS 5,465 被引量:1
  • 6[6]Pohlmeyer E G,Mehdi N,Clarke D,et al.Evaluation of chronic oral toxicity and carcinogenic potential of lornoxicam in rat[J].Food-Chem-Toxocol,1997,35:ISS 9,909 被引量:1
  • 7[7]Rosenow DE,van Krieken F,Stolke D,et al.Intravenous administration of lornoxicam,a new NSAID,and pethidine for postoperation pain[J].Clin Drug Invest,1996,11(1):11 被引量:1
  • 8[8]Balfour JA,Fitton A,Barradell LB.Lornixicam:A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions[J].Drugs,1996,51(Apr):639 被引量:1
  • 9[9]Radhofer W S,Rabasseda.Lornoxicam,a new potent NSAID with an improved tolerability profile[J].Drugs of Today,2000,36(1):55 被引量:1
  • 10[10]Berry H,Bird HA,Black C,et al.A double blind,multicentre,placebo controlled trial of lornoxicam in patients with osteoarthritis of the hip and knee[J].Ann Rheum Dis,1992,51:238 被引量:1

共引文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部